Virax Biolabs Group Limited
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Virax Biolabs Group Limited's balance sheet done over the years? Its assets were worth $5,483,969 last year, which is less than in the previous period. 6% of Virax Biolabs Group Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $345,194, which means an decrease by -62% compared compared to last year.

Debt to Assets

Virax Biolabs Group Limited (NASDAQ:VRAX): Debt to assets
2020 22609 1.23M 5474.51%
2021 94118 871.43K 925.9%
2022 48706 1.24M 2557%
2023 9812416 908.40K 9.26%
2024 5483969 345.19K 6.29%

VRAX Balance Sheet (2020 – 2024)

2024 2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
3.58M9.35M21.75K17.62K22.60K
Short term investments
77.32K49.25K5.99K00
Net receivables
217.84K0-19280
Inventory
60.38K24.09K20.95K21.07K0
Other current assets
512.78K281.47K5.99K-40
Total current assets
4.38M9.63M48.70K39.62K22.60K
Non-current assets:
Property, Plant and Equipment
1.10M0000
Goodwill
00000
Intangible assets
49.77K178.40K000
Long term investments
00054.49K0
Other non-current assets
-49.77K-178.40K000
Total non-current assets
1.10M178.40K054.49K0
Total assets
5.48M9.81M48.70K94.11K22.60K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
038.25K-80-759.37K
Short term debt
47.95K146.25K3.75K179.48K759.37K
Total current liabilities
168.84K908.40K1.24M871.43K1.23M
Non-current liabilities:
Long term debt
176.34K0000
Deferred tax
00000
Other non-current liabilities
00000
Total non-current liabilities
176.34K0000
Total liabilities
345.19K908.40K1.24M871.43K1.23M
Data sourceData sourceData source